Imaging scans for neuroblastoma and related tumors
Part of Cancer clinical trials.
This trial uses special PET/CT or SPECT/CT scans that light up certain types of tumor cells (neuroblastoma and pheochromocytoma/paraganglioma). The scans help doctors see where the cancer is, how far it has spread, and whether treatment is working.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 6 months old.
- You have or are suspected of having neuroblastoma or pheochromocytoma/paraganglioma.
- You are able to have a PET/CT or PET/MRI scan (no MRI safety issues for the MRI part).
- You are not pregnant or breastfeeding, or you agree to follow the study's pregnancy prevention and breastfeeding rules.
- You are willing to possibly have two separate scans up to 28 days apart without any cancer treatment in between.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses a special PET scan called 18F-mFBG to take pictures of neuroblastoma tumors. It helps doctors see where the cancer is and whether treatment is working.
This early-phase trial uses a special PET/CT scan to help evaluate neural crest tumors, which include conditions like neuroblastoma. It may help doctors understand how well the scan shows tumor activity to guide diagnosis and treatment planning.
This trial tests a new PET scan tracer (18F-MFBG) against the standard SPECT scan (123I-MIBG) to see if it better shows neuroblastoma tumors. It's for children whose cancer has come back or hasn't responded to treatment.
This trial compares two different nuclear medicine scans to see which one best shows where neuroblastoma is in a child’s body. The results may help doctors choose the most helpful scan for planning care.
This study tests how well a new PET/CT scan using 68Ga-DOTATATE can find neuroblastoma. It’s for children and young adults who are being planned for a different scan (123I-MIBG) to compare imaging results.
This trial improves a special PET scan (a type of brain/body imaging) using 18F-DOPA, to better show how certain conditions behave in the body. If you or your child may have one of the listed conditions, the study may help your doctors get clearer scan results.
Hear when a new Neuroblastoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.